US FDA approves AstraZeneca's drug for breast cancer-March 2024-www.financetom.com

US FDA approves AstraZeneca's drug for breast cancer

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

US FDA approves AstraZeneca's drug for breast cancer

Jan 17, 2025 10:50 AM

Jan 17 (Reuters) - The U.S. Food and Drug Administration

has approved AstraZeneca ( AZN ) and partner Daiichi Sankyo's ( DSKYF )

precision drug to treat a type of breast cancer, the

health regulator said on Friday.

(Reporting by Sriparna Roy in Bengaluru; Editing by Devika

Syamnath)

Previous page： First Solar Insider Sold Shares Worth $1,913,418, According to a Recent SEC Filing Next page： Australian telecom firm Telstra's annual profit falls on weak enterprise performance

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

First Solar Insider Sold Shares Worth $1,913,418, According to a Recent SEC Filing

Aug 14, 2024

06:02 PM EDT, 08/14/2024 (MT Newswires) -- Patrick James Buehler, Chief Product Officer, on August 13, 2024, sold 8,619 shares in First Solar ( FSLR ) for $1,913,418. Following the Form 4 filing with the SEC, Buehler has control over a total of 3,468 shares of the company, with 3,468 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1274494/000112760224022209/xslF345X03/form4.xml Price: 226.25, Change: +0.71,...

Australian telecom firm Telstra's annual profit falls on weak enterprise performance

Aug 14, 2024

(Reuters) -Australia's top telecom firm Telstra Group ( TTRAF ) posted nearly a 16% drop in its full-year profit on Thursday, as growth in its mobile segment was outweighed by the weak performance of enterprise and wholesale business. Telstra's ( TTRAF ) fixed enterprise segment, which provides tech solutions, network capacity and cloud services to government and large businesses, continued...

Edwards Lifesciences Insider Sold Shares Worth $330,420, According to a Recent SEC Filing

Aug 14, 2024

06:01 PM EDT, 08/14/2024 (MT Newswires) -- Donald E Bobo Jr, Corporate Vice President, Strategy & Corporate Development, on August 14, 2024, sold 5,000 shares in Edwards Lifesciences ( EW ) for $330,420. Following the Form 4 filing with the SEC, Bobo has control over a total of 220,704 shares of the company, with 46,936 shares held directly and 173,769...

Brazilian meat processor BRF posts net profit of $201 mln for second quarter

Aug 14, 2024

SAO PAULO, Aug 14 (Reuters) - Brazilian pork and poultry processor BRF SA ( BRFS ) reported net profit of 1.1 billion reais ($201 million) in the second quarter, according to a financial statement released on Wednesday. ($1 = 5.4714 reais) ...